跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMLODIPINE TABLETS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AMLODIPINE TABLETS
Authorized
STANDARD
AMLODIPINE TABLETS
nora pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5c0d26a18cadd8a2
Company
nora pharma inc
Type
Standard
Approval Details
Approval Id
5c0d26a18cadd8a2
Drug Approval Canada Name
AMLODIPINE TABLETS
Product Name
AMLODIPINE TABLETS
Status
Cancelled Post Market
Status Date
2022-07-25
Original Market Date
2017-10-25
Din
02444461
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:28.08
Atc Original
C08CA01 AMLODIPINE
Atc Name
c 08 ca 01
Aig Number
0131437001
Company Name
nora pharma inc
Company Address
1565 Lionel-Boulet Blvd., Varennes, Quebec, Canada, J3X 1P7
Active Ingredients
AMLODIPINE (AMLODIPINE BESYLATE)
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5c0d26a18cadd8a2
Type
Standard
Back to Health Canada Approvals